Véronique Bissay

Bromocriptine Therapy in Multiple Sclerosis

Véronique Bissay, Nina De Klippel, Luc Herroelen et al. · Clinical Neuropharmacology · 1994 · 45 citations

SCN4A variants and Brugada syndrome: phenotypic and genotypic overlap between cardiac and skeletal muscle sodium channelopathies

Véronique Bissay, Sophie CH Van Malderen, Kathelijn Keymolen et al. · European Journal of Human Genetics · 2015 · 41 citations · Full text

Cardiac Muscle, Channelopathies, Cardiomyopathy +7

Safety and efficacy of natalizumab in Belgian multiple sclerosis patients: subgroup analysis of the natalizumab observational program

Vincent Van Pesch, E Bartholomé, Véronique Bissay et al. · Acta Neurologica Belgica · 2014 · 23 citations

Disease Progression, Systemic Scleroderma, Medicine +10

Natalizumab treatment shows low cumulative probabilities of confirmed disability worsening to EDSS milestones in the long-term setting

María Trojano, Helmut Butzkueven, Ludwig Kappos et al. · Multiple Sclerosis and Related Disorders · 2018 · 18 citations · Full text

Late onset painful cold-aggravated myotonia: Three families with SCN4A L1436P mutation

Véronique Bissay, Kathelijn Keymolen, Willy Lissens et al. · Neuromuscular Disorders · 2011 · 16 citations

Three Families, Painful Cold-aggravated Myotonia, Allergy +4